Background: There is a paucity of data on the mortality of patients admitted to the intensive care unit (ICU), despite the fact that human immunodeficiency virus (HIV)-related diseases represent a significant burden to health care resources particularly in sub-Saharan Africa. Aim: To describe the outcome and prognostic factors of HIV-infected patients requiring mechanical ventilation in an ICU. Design: Prospective observational study. Methods: All 54 patients (34.8 6 10.4 years, 38 females) admitted with confirmed HIV from October 2012 until May 2013 were enrolled. Disease severity was graded according to APACHEII score. Admission diagnoses, clinical features and laboratory investigations, complications and outcomes were recorded. Results: The mean length of ICU stay was 11.0 days (range: 1-49 days), and 33 patients survived (ICU mortality: 38.9%). The in-hospital mortality at 30 days was 48.1%. ICU mortality was associated with an AIDS-defining diagnosis (OR ¼ 7.97, P ¼ 0.003). Non-survivors had higher APACHEII scores (25.8 vs. 18.6, P ¼ 0.001) and lower mean admission CD 4 counts (102.5 vs. 225.2, P ¼ 0.014). Multiple logistical regression analysis confirmed the independent predictive value of WHO stage 4 disease (P ¼ 0.008), lower mean CD 4 count on admission (P ¼ 0.057) and higher APACHEII score (P ¼ 0.010) on ICU mortality, and WHO stage 4 (P ¼ 0.007) and higher APACHE II score (P ¼ 0.003) on 30-day mortality. Conclusions: The ICU mortality of mechanically ventilated HIV-positive patients was high. WHO stage 4 disease and a higher APACHEII score were predictive of both ICU and 30-day mortality, whereas a low CD 4 count on admission was associated with ICU mortality.
Background
South Africa currently has the highest HIV prevalence in the world with an estimated 6.1 million of the estimated 34 million infected individuals worldwide. [1] [2] [3] [4] Over one-third of females aged 30-34 years and almost 25% of males aged 35-39 years are infected with HIV. 1, 4 Several studies, mostly from developed countries, have assessed the outcomes of HIV-infected patients admitted to intensive care units (ICUs) retrospectively, and reported mortality rates range from 9 to 75%. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] Since the widespread availability of highly active antiretroviral therapy (HAART), HIV infection has become a manageable chronic disease. This has also been mirrored by an improved ICU survival in the HAART era compared to the pre-HAART era. 5, 19 Several recent studies from developed countries have only linked non-HIV-related variables to outcomes. They reported no association between HIV-related variables, such as CD 4 count and the presence of AIDS-defining conditions, and outcome. 5, 8, 17 The majority of prior studies were retrospective in nature and not conducted in a setting with high HIV prevalence and limited ICU resources. The aim of this prospective observational study was to describe the outcome and prognostic factors of HIV-infected patients requiring mechanical ventilation in an ICU of a tertiary referral centre in a resource constrained setting.
Our secondary aim was to specifically evaluate the role of CD 4 counts in predicting outcome, as it is well described that CD 4 counts drop in acutely ill patients and patients with tuberculosis (TB). [20] [21] [22] [23] 
Methods

Study population
This prospective observational study was conducted from October 2012 until May 2013 at Tygerberg Academic Hospital, a 1380-bed facility in Cape Town, South Africa. It is one of two referral centres in the city and renders a tertiary service to a population of about 1.5 million people. All patients admitted to the Medical ICU with confirmed HIV (either known at admission or newly diagnosed) were enrolled. The study was approved by the Stellenbosch University Health Research Ethics Committee. Informed consent was obtained from all subjects or their legal representative prior to data collection.
Clinical data
Apart from documenting patient demographics, we specifically noted the reason for ICU admission. We also documented whether a patient met the criteria for AIDS according to the WHO staging criteria and/or the CDC criteria. 24, 25 Moreover, patients were classified according to their HAART status into five categories: (i) naïve (never been on HAART and not started on HAART in ICU); (ii) virally suppressed (confirmed by Viral Load [VL]); (iii) non-compliant/failed (previous HAART exposure or currently on HAART but failing as confirmed by VL); (iv) Initiated in ICU; and (v) Other (e.g. prevention of mother to child transmission (PMTCT) or on HAART for less than 3 months).
HAART was continued in ICU if patients were on HAART on admission to ICU. The presence of TB, both pulmonary tuberculosis (PTB) and extrapulmonary, previous TB and PCP was documented.
Laboratory and related investigations
Laboratory investigations included: white blood cell count, platelet count, serum haemoglobin (Hb), serum albumin, C-reactive protein (CRP), creatinine and alanine aminotransferase (ALT 
Statistical aspects
Descriptive statistics and chi-square (not Yates corrected) or Fisher's exact tests (where indicated) were performed on dichotomous categorical variables, and t-tests on continuous data. Unless stated otherwise, data is displayed as means and standard deviation (SD). Stata (version 13, StataCorp LP) was used to construct multiple logistic regression models to predict survival in ICU and at 30 days. A forward-stepwise selection method was used with entry probability set at 0.1. Likelihood ratio tests were used to select the final model. Independent variables specified for each model were those selected firstly on clinical significance and univariate analysis: APACHEII score, WHO stage 4 and CD 4 on admission (continuous variable).
Results
Patients
Fifty-four HIV-infected patients (aged 34.8 6 10.4 years, 38 females) were admitted to ICU over the study period (three patients admitted twice during the same hospital admission, 57 admissions in total). The mean length of ICU stay was 11.0 days (range 1-49 days).
In total, 21 of 54 admissions did not survive the ICU admission (ICU mortality 38.9%); another 5 patients died after ICU discharge, but within 30 days of ICU admission (30-day mortality: 48.1%). The three patients who were readmitted all survived both admissions.
The reasons for ICU admission are summarized in Table 1 . The majority of patients (n ¼ 39, 72.2%) were admitted with respiratory failure secondary to infections or neuromuscular weakness. Sepsis contributed to the admission in 45 patients (83.3%), with almost one-third of these patients (n ¼ 14) presenting with septic shock. Only 8 patients (14.8%) were admitted for reasons unrelated to HIV, including peripartum complications, drug overdose, malaria or a postictal state with decreased level of consciousness. Only one of these did not survive ICU admission. AIDS defining conditions (WHO stage 4) were present in
Clinical and laboratory data
The categorical and continuous data are presented in Tables  2-5 . Both ICU and 30-day mortality were significantly associated with an AIDS-defining diagnosis (OR ¼ 7.97, P ¼ 0.003 and OR ¼ 7.14, P ¼ 0.007, respectively). PCP (n ¼ 6) carried a 100% mortality.
The mean acute CD 4 count on admission was lower in nonsurvivors than survivors (102.5 vs. 225.2, P ¼ 0.014). The median baseline CD 4 
Management, course and complications
Fourteen of the 54 patients stayed in ICU longer than 2 weeks, and 9 of them underwent tracheostomy. A total of 25 out of the 54 patients (46.3%) developed renal failure (Tables 2 and 4) . Neither renal failure, ARDS, DIC nor MODS were associated with increased mortality. The ICU course was complicated by the development of VAP in 12 patients (22.2%), which was associated with non-survival at 30 days (P ¼ 0.006).
Discussion
In this prospective observational study, we found that the mortality of HIV-infected patients admitted to ICU to be as high as 38.9%. Furthermore, 48.1% were not alive 30 days after ICU discharge. WHO stage 4 disease (P ¼ 0.008), a low CD 4 count on admission (P ¼ 0.057) and a higher APACHEII score (P ¼ 0.010)
were associated with ICU mortality, whereas WHO stage 4 disease (P ¼ 0.007) and a higher APACHE II score (P ¼ 0.003) were also associated with 30-day mortality. While our observed ICU mortality rate was marginally higher than mortality rates reported in studies performed on HIV-positive patients in developed countries (where figures range from 9 to 31%), it was lower than the 55% reported in a Brazilian study. 5, 6, 15 Moreover, a mortality rate of 38.9% is within the anticipated 30-40%, given a mean APACHEII score of 21.4, 26 making the mortality for this group of patients similar to the expected mortality for HIV-negative patients. It should also be emphasized that all patients in our study required mechanical ventilation, which is known to be an independent predictor of mortality. 5, 7, 9, [31] [32] [33] Several other factors may have contributed to our high mortality rate. Our cohort was more comparable to those described in the pre-HAART era, as only 37% of patients had been exposed to HAART and only 5.6% were virally suppressed. In addition, only 14.8% of our cohort presented with conditions unrelated to HIV, in contrast with other recent studies reporting that approximately half of ICU admissions were for non-HIV related illnesses. [5] [6] [7] 17, 31, 32, 34 We found that both ICU and 30-day mortality were significantly associated with an AIDS-defining diagnosis (WHO stage 4) which was present in 27.8% of our patients. Extrapulmonary TB was not independently associated with mortality. The reported mortality of patients who require mechanical ventilation because of PCP infection is as high as 81%. 7, 10, 11, 31 The six cases of PCP in our cohort did worse than expected: none of them survived ICU admission. Patients who did not survive ICU had a lower mean acute CD 4 count, but not a lower mean preadmission CD 4 count. Moreover, a CD 4 count < 50 cells/mm 3 was strongly associated with both ICU and 30-day mortality. Acute illness is known to have a profound effect on CD 4 count homeostasis. A recent ICU study where CD 4 levels were taken in 102 ICU patients, only three of whom were HIV positive demonstrated this; 41% had CD 4 levels <400 cells/mm 3 , and 29 % were <300 cells/mm 3 .
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Furthermore, low CD 4 cell counts in patients diagnosed with TB and subsequent elevation in CD 4 count after initiation of anti-TB treatment, has been described in several case series, suggesting that TB itself has an impact on CD 4 cell homeostasis. 22, 23 As nearly half of our patients had active TB, the TB may have contributed to the observed drop in acute CD 4 count. In addition, it should also be emphasized that most recent studies do not report CD 4 counts on admission, and that baseline counts (done up to 3-6 months prior to admission) are often used as surrogates. 5, 8, 17 Our data confirm that baseline CD 4 counts done up to 4 months prior to admission do not predict survival.
Pulmonary TB was associated with a decreased 30-day survival in the univariate analysis, but not with an increased ICU mortality. It was also not found to be an independent predictor of mortality by means of the multivariate analysis. In a recent study, we found that PTB has an ICU mortality rate of 44.2% and an in-hospital mortality rate of 59%, and that neither the HIV status nor the presence of AIDS influenced mortality. 35 The major strength of our study was the fact that the high prevalence of HIV in our setting enabled us to enrol a large number of patients prospectively over a relatively short time period, ensuring that the standard of care remained unchanged during the study period and thus limiting the effect of changes in critical care over the years. Furthermore, all our patients required mechanical ventilation whereas in previous studies the number of ventilated patients was highly variable. Potential weaknesses of our study include the fact that limited ICU resources may have introduced a selection bias toward healthier patients being admitted to ICU. This tendency to admit healthier patients with a better prognosis to ICU could account for the lack of significance of certain parameters in predicting mortality. Delays in referral and patient behaviour, may also have contributed to a delay in treatment and to the high incidence of acute renal failure and other organ failures.
Conclusions
The ICU mortality of mechanically ventilated HIV-positive patients was high. WHO stage 4 disease and a higher APACHEII score independently predicted both ICU and 30-day mortality, whereas low admission CD 4 counts were associated with mortality in the ICU. Preadmission CD 4 counts did not predict non-survival. 
